BACKGROUND: Due to chronic inflammatory status, rheumatoid arthritis (RA) patients are exposed to changes in left ventricular (LV) geometry and function. We assessed prevalence, factors associated with, and prognostic role of concentric LV geometry and systolic dysfunction (LVSD) detected by echocardiography in a large cohort of patients with RA and normal blood pressure. HYPOTHESIS: Changes in LV geometry and function are widely detectable in normotensive patients with RA analyzed in primary prevention. METHODS: We prospectively analyzed 194 normotensive RA patients without overt cardiac disease recruited between March 2014 and May 2016, compared with 194 non-RA matched controls. Relative wall thickness >0.43 defined concentric LV geometry. LVSD was defined as impaired global longitudinal strain (GLS). The prespecified study endpoints were all-cause hospitalization and hospitalization for cardiovascular cause. RESULTS: The 194 normotensive subjects (mean age, 54 years; 63% female; RA duration 13 years) had a prevalence of LV concentric geometry 5-fold higher and LVSD 5-fold higher than non-RA matched controls. Body mass index, LVSD, and diastolic dysfunction were associated with concentric LV geometry, while worsening renal function and older age were associated with LVSD. LVSD was independently related to the study endpoints (HR 2.37 [1.24-4.53], p = 0.009, for all-causes hospitalization and HR 6.60 [1.47-29.72], p = 0.01 for cardiovascular hospitalization). CONCLUSIONS: Despite normotensive status, a consistent proportion of RA patients analyzed in primary prevention have cardiac abnormalities detectable by echocardiography. LVSD is a strong prognosticator of adverse outcome at midterm period in these patients.
BACKGROUND: Due to chronic inflammatory status, rheumatoid arthritis (RA) patients are exposed to changes in left ventricular (LV) geometry and function. We assessed prevalence, factors associated with, and prognostic role of concentric LV geometry and systolic dysfunction (LVSD) detected by echocardiography in a large cohort of patients with RA and normal blood pressure. HYPOTHESIS: Changes in LV geometry and function are widely detectable in normotensive patients with RA analyzed in primary prevention. METHODS: We prospectively analyzed 194 normotensive RApatients without overt cardiac disease recruited between March 2014 and May 2016, compared with 194 non-RA matched controls. Relative wall thickness >0.43 defined concentric LV geometry. LVSD was defined as impaired global longitudinal strain (GLS). The prespecified study endpoints were all-cause hospitalization and hospitalization for cardiovascular cause. RESULTS: The 194 normotensive subjects (mean age, 54 years; 63% female; RA duration 13 years) had a prevalence of LV concentric geometry 5-fold higher and LVSD 5-fold higher than non-RA matched controls. Body mass index, LVSD, and diastolic dysfunction were associated with concentric LV geometry, while worsening renal function and older age were associated with LVSD. LVSD was independently related to the study endpoints (HR 2.37 [1.24-4.53], p = 0.009, for all-causes hospitalization and HR 6.60 [1.47-29.72], p = 0.01 for cardiovascular hospitalization). CONCLUSIONS: Despite normotensive status, a consistent proportion of RApatients analyzed in primary prevention have cardiac abnormalities detectable by echocardiography. LVSD is a strong prognosticator of adverse outcome at midterm period in these patients.
Authors: D H Solomon; N J Goodson; J N Katz; M E Weinblatt; J Avorn; S Setoguchi; C Canning; S Schneeweiss Journal: Ann Rheum Dis Date: 2006-06-22 Impact factor: 19.103
Authors: Kaisa M Mäki-Petäjä; Frances C Hall; Anthony D Booth; Sharon M L Wallace; Philip W P Bearcroft; Srinivasan Harish; Anita Furlong; Carmel M McEniery; John Brown; Ian B Wilkinson Journal: Circulation Date: 2006-09-04 Impact factor: 29.690
Authors: Miguel A Gonzalez-Gay; Carlos Gonzalez-Juanatey; Maria J Lopez-Diaz; Angela Piñeiro; Carlos Garcia-Porrua; Jose A Miranda-Filloy; William E R Ollier; Javier Martin; Javier Llorca Journal: Arthritis Rheum Date: 2007-02-15
Authors: Hilal Maradit-Kremers; Cynthia S Crowson; Paulo J Nicola; Karla V Ballman; Véronique L Roger; Steve J Jacobsen; Sherine E Gabriel Journal: Arthritis Rheum Date: 2005-02
Authors: Margaret M Redfield; Steven J Jacobsen; John C Burnett; Douglas W Mahoney; Kent R Bailey; Richard J Rodeheffer Journal: JAMA Date: 2003-01-08 Impact factor: 56.272
Authors: Melinda Wong; Ling Toh; Andrew Wilson; Kevin Rowley; Connie Karschimkus; David Prior; Evange Romas; Laurence Clemens; George Dragicevic; Harry Harianto; Ian Wicks; Geoff McColl; James Best; Alicia Jenkins Journal: Arthritis Rheum Date: 2003-01
Authors: Giovanni de Simone; Stephen R Daniels; Thomas R Kimball; Mary J Roman; Carmela Romano; Marcello Chinali; Maurizio Galderisi; Richard B Devereux Journal: Hypertension Date: 2004-11-22 Impact factor: 9.897
Authors: Elena Bartoloni; Fabio Angeli; Elisa Marcucci; Carlo Perricone; Giacomo Cafaro; Clara Riccini; Lorenzo Spighi; Benedetta Gildoni; Claudio Cavallini; Paolo Verdecchia; Roberto Gerli Journal: Ann Med Date: 2021-12 Impact factor: 4.709
Authors: Lilia M Sierra-Galan; Mona Bhatia; Angel Leovigildo Alberto-Delgado; Javier Madrazo-Shiordia; Carlos Salcido; Bernardo Santoyo; Eduardo Martinez; Maria Elena Soto Journal: Front Cardiovasc Med Date: 2022-07-13